The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInc&gwth Vct Regulatory News (IGV)

Share Price Information for Inc&gwth Vct (IGV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 70.00
Bid: 68.50
Ask: 71.50
Change: 1.50 (2.14%)
Spread: 3.00 (4.38%)
Open: 70.00
High: 71.50
Low: 71.50
Prev. Close: 70.00
IGV Live PriceLast checked at -
The Income & Growth VCT is an Investment Trust

To provide an attractive return by maximising dividend distributions from the income and capital gains generated by investment in unquoted companies. This may include AIM companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement - 3rd Quarter

16 Sep 2020 15:31

RNS Number : 2135Z
Income & Growth VCT (The) PLC
16 September 2020
 

The Income & Growth VCT plc

(the "Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 June 2020

 

The Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 30 June 2020. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

 

 

At 30 June 2020

At 31 March 2020

 

Net assets attributable to shareholders

 

£87,883,180

£78,775,672

Shares in issue

114,844,575

115,068,452

Net asset value (NAV) per share

 

76.52 pence

68.46 pence

Cumulative dividends paid to date per share

117.50 pence

 

 

117.50 pence

 

 

Total return per share since inception (NAV basis)

194.02 pence

185.96 pence

 

 

The net increase in the NAV per share of 8.06 pence over the quarter represents a period of encouraging recovery. The Company's portfolio valuations at 30 June 2020 have increased from the values held at 31 March 2020. The valuations at 31 March 2020 had been adversely affected by the economic disruption and uncertainty resulting from the outbreak of the COVID-19 Global Pandemic. However, over this quarter to 30 June 2020, more clarity has emerged on the impact of the Company's portfolio such that, to date, this has been more modest than was initially expected with much of the portfolio demonstrating a strong degree of resilience. The net increase from portfolio movements for the quarter is 8.06 pence per share, being the principal cause of a positive 11.8% NAV return for the quarter.

 

 

INVESTMENT ACTIVITY

 

New investment during the period

On 29 June 2020, the Company invested £0.32 million into a new investee company, Andersen EV, a designer of electric vehicle (EV) charge points.

 

Further investments during the period

On 5 May 2020, the Company invested a further £0.63 million into Rotageek, a provider of cloud-based workforce management software to help larger retail and leisure organisations predict and meet demand to schedule staff effectively.

 

On 26 May 2020, the Company invested a further £0.98 million into MyTutorweb (trading as MyTutor), an existing portfolio company and digital marketplace that connects school pupils who are seeking private one-to-one tutoring with university students.

 

Further investments after the period end

On 1 September 2020, a further £1.54 million was invested into existing portfolio company, Buster and Punch Holdings Limited, a London-based interiors brand.

 

Realisations during the period

On 30 April 2020, the Company partially realised its holding in Omega Diagnostics Group plc, generating proceeds of £0.64 million.

 

Realisations after the period end

After the period end, on 14 August 2020, the Company sold its investment in Tovey Management Limited (trading as Access IS) to ASSA ABLOY AB for £7.15 million. Over the five years this investment was held, it generated cash proceeds of £8.38 million compared to an original investment cost of £3.13 million, which is a multiple on cost of 2.5x and an IRR of 23.4%.

 

Also after the period end, on 2 September 2020, the Company sold its investment in Blaze Signs Holdings Limited via a secondary buyout backed by Elaghmore LLP and has received cash proceeds of £1.20 million. Over the fourteen years this investment was held, it has generated cash proceeds of £3.39 million compared to an original investment cost of £1.34 million, which is a multiple on cost of 2.5x and an IRR of 13.1%.

 

Finally, on 10 September 2020, the Company partially realised its remaining holding in Omega Diagnostics Group plc, generating proceeds of £0.41 million.

 

The impact of these three realisations on the NAV per share of 76.52 pence at 30 June 2020 is estimated to be an increase of 1.65 pence per share. The Board emphasises that this increase in NAV per share from these three realisations is in isolation from other changes in the Company's balance sheet, including valuation and other transaction movements in the Company's investment portfolio, that may also have affected the NAV per share during the current quarter since 30 June 2020.

 

INTERIM DIVIDEND

After the period end, on 10 July 2020, the Company paid a 3.00 pence per share interim dividend in respect of the year ending 30 September 2020, to all Shareholders whose names were on the Register on 19 June 2020, including all shareholders who invested in the 2019/20 fundraising. Following payment of this dividend, 874,986 ordinary shares in the Company were allotted to existing Shareholders registered for the Dividend Investment Scheme, at a price of 65.50 pence per share and a total consideration of £572,779. Following this allotment, the number of Ordinary Shares in issue is 115,719,561.

 

On 25 August 2020, the Company declared a second interim dividend of 11.00 pence per share in respect of the year ending 30 September 2020. This dividend will be paid on 28 September 2020 to Shareholders on the Register on 4 September 2020.

 

The two interim dividends referred to above totalling 14.00 pence per share will reduce the Company's NAV per share at 30 June 2020 of 76.52 pence and increase cumulative dividends paid up to 30 June 2020 of 117.50 pence per share, by 3.00 pence and 11.00 pence per share on their respective payment dates.

 

SHARE BUYBACK

On 19 June 2020, the Company purchased 223,877 of the Company's own ordinary shares at a price of 62.00 pence per share for cancellation.

 

Please note that all of the information above is unaudited.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

 

For further information, please contact:

Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600

 

 

LEI: 213800FPC15FNM74YD92

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUNASRRSUKAAR
Date   Source Headline
9th May 202411:29 amRNSDividend Declaration - Replacement
9th May 20247:00 amRNSDividend Declaration
1st May 20247:00 amRNSTotal Voting Rights and Capital
2nd Apr 20249:32 amRNSTotal Voting Rights and Capital
28th Mar 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Mar 20241:00 pmRNSTransaction in Own Shares and Total Voting Rights
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
29th Feb 20242:00 pmRNSResult of Annual General Meeting
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
27th Feb 20249:30 amRNSInterim Management Statement
1st Feb 202411:35 amRNSVoting Rights and Capital
22nd Jan 20241:00 pmRNSTransaction in Own Shares and Total Voting Rights
15th Jan 20249:04 amRNSAnnual Financial Report
2nd Jan 20242:30 pmRNSVoting Rights and Capital
1st Dec 20237:00 amRNSTotal Voting Rights
8th Nov 202310:20 amRNSDirector/PDMR Shareholding
8th Nov 202310:15 amRNSIssue of Equity and Total Voting Rights
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSStatement re Change of Registrar
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20234:00 pmRNSTransaction in Own Shares
25th Sep 202311:00 amRNSDividend Declaration
20th Sep 20233:30 pmRNSInterim Management Statement
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:02 pmRNSTransaction in Own Shares
14th Jun 20237:00 amRNSHalf-year Report
1st Jun 20237:00 amRNSTotal Voting Rights
26th May 20235:15 pmRNSDirector/PDMR Shareholding
26th May 20235:00 pmRNSIssue of Equity and Total Voting Rights
26th May 20234:36 pmRNSNet Asset Value(s)
2nd May 202310:00 amRNSTotal Voting Rights
13th Apr 20231:00 pmRNSDividend Declaration
3rd Apr 20237:00 amRNSTotal Voting Rights
29th Mar 202311:00 amRNSTransaction in Own Shares
27th Mar 20231:00 pmRNSRealisation of investment:Tharstern Group Limited
3rd Mar 20235:04 pmRNSTransaction in Own Shares
1st Mar 20237:00 amRNSTotal Voting Rights
22nd Feb 20233:30 pmRNSInterim Management Statement
22nd Feb 20233:15 pmRNSResult of AGM
7th Feb 20237:01 amRNSDirector/PDMR Shareholding
7th Feb 20237:00 amRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:14 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
11th Jan 20235:34 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.